Abstract Background and Objectives Cognitive disorders may be an early sign of
neuropsychiatric disorders; however, it remains unclear whether the screening measures …

Parkinson's disease (PD) is a progressive neurodegenerative disease characterized by
motor symptoms such as rigidity, rest tremor, and bradykinesia. However, a growing body of …

More than half of patients who recover from COVID-19 experience fatigue. We studied
fatigue using neuropsychological and neurophysiological investigations in post-COVID-19 …

Bergamo province was badly hit by the coronavirus disease 2019 (COVID-19) epidemic. We
organised a public-funded, multidisciplinary follow-up programme for COVID-19 patients …

Objective The Montreal Cognitive Assessment (MoCA; Nasreddine et al., 2005) is a
cognitive screening tool that aims to differentiate healthy cognitive aging from Mild Cognitive …

Considering the mechanisms capable of causing brain alterations in COVID-19, we aimed to
study the occurrence of cognitive abnormalities in the months following hospital discharge …

Background Clinical investigations have argued for long-term neurological manifestations in
both hospitalised and non-hospitalised COVID-19 patients. It is unclear whether long-term …

Background and purpose Cognitive dysfunction has been observed following recovery from
COVID‐19. To the best of our knowledge, however, no study has assessed the progression …

Abstract The Montreal Cognitive Assessment (MoCA) is a cognitive screening instrument
developed to detect mild cognitive impairment (MCI). It is a simple 10 min paper and pencil …

Background: The Montreal Cognitive Assessment (MoCA) has a high sensitivity for detecting
cognitive dysfunction. Swedish normative data does not exist and international norms are …